The Indonesia Research Partnership on Infectious Disease (INA-RESPOND) is a collaborative initiative between United States and Indonesian government institutions formed to promote and conduct high-quality infectious disease clinical research in Indonesia through development of a collaborative, sustainable, and well-recognized research network.
INA-RESPOND has been conducting clinical research since 2011. Infectious diseases that have been prioritized by Ministry of Health of Republic Indonesia include Malaria, Avian Influenza, Dengue, AIDS (HIV), Tuberculosis, or in short, MADAT, and Neglected Infectious Diseases.
The aim of the INA-RESPOND is to conduct basic and clinical research, increase the understanding of the pathogenesis of diseases, and prevent and treat infectious disease based on the concerns of the country and in alignment with the priorities of the Indonesian Ministry of Health. It is intended that the research conducted by this network will aid in the development of public health policies and build a sustainable research capacity within Indonesia.
This beneficial collaboration allows both countries to partner in research and study infectious diseases that affect Indonesia, the surrounding region and the global community. As the world becomes increasingly smaller and travelling becomes easier, responsible global health citizenship demands international and domestic collaborations to face the challenges imposed by diseases, particularly infectious diseases that respect no geographic boundaries.